230 related articles for article (PubMed ID: 28300321)
1. Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch.
Mulcrone PL; Campbell JP; Clément-Demange L; Anbinder AL; Merkel AR; Brekken RA; Sterling JA; Elefteriou F
J Bone Miner Res; 2017 Jul; 32(7):1442-1454. PubMed ID: 28300321
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
[TBL] [Abstract][Full Text] [Related]
3. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
[TBL] [Abstract][Full Text] [Related]
5. β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells.
Huang Z; Li G; Zhang Z; Gu R; Wang W; Lai X; Cui ZK; Zeng F; Xu S; Deng F
BMC Cancer; 2019 Nov; 19(1):1142. PubMed ID: 31771535
[TBL] [Abstract][Full Text] [Related]
6. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.
Zhang Z; Wang H; Ikeda S; Fahey F; Bielenberg D; Smits P; Hauschka PV
Am J Pathol; 2010 Sep; 177(3):1459-69. PubMed ID: 20651241
[TBL] [Abstract][Full Text] [Related]
7. β2-Adrenergic receptor signaling in osteoblasts contributes to the catabolic effect of glucocorticoids on bone.
Ma Y; Nyman JS; Tao H; Moss HH; Yang X; Elefteriou F
Endocrinology; 2011 Apr; 152(4):1412-22. PubMed ID: 21266510
[TBL] [Abstract][Full Text] [Related]
8. Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
Ray A; Alalem M; Ray BK
J Biol Chem; 2013 Sep; 288(38):27232-27242. PubMed ID: 23926105
[TBL] [Abstract][Full Text] [Related]
9. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
10. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
11. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
12. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling.
Kumar BN; Rajput S; Dey KK; Parekh A; Das S; Mazumdar A; Mandal M
BMC Cancer; 2013 Jun; 13():273. PubMed ID: 23731702
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A.
Deckers MM; van Bezooijen RL; van der Horst G; Hoogendam J; van Der Bent C; Papapoulos SE; Löwik CW
Endocrinology; 2002 Apr; 143(4):1545-53. PubMed ID: 11897714
[TBL] [Abstract][Full Text] [Related]
15. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Bussard KM; Venzon DJ; Mastro AM
J Cell Biochem; 2010 Dec; 111(5):1138-48. PubMed ID: 20683902
[TBL] [Abstract][Full Text] [Related]
16. β2-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer.
Chang A; Le CP; Walker AK; Creed SJ; Pon CK; Albold S; Carroll D; Halls ML; Lane JR; Riedel B; Ferrari D; Sloan EK
Brain Behav Immun; 2016 Oct; 57():106-115. PubMed ID: 27321906
[TBL] [Abstract][Full Text] [Related]
17. Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.
Bachelier R; Confavreux CB; Peyruchaud O; Croset M; Goehrig D; van der Pluijm G; Clézardin P
Int J Cancer; 2014 Sep; 135(6):1319-29. PubMed ID: 24615579
[TBL] [Abstract][Full Text] [Related]
18. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
[TBL] [Abstract][Full Text] [Related]
19. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
Haider MT; Holen I; Dear TN; Hunter K; Brown HK
Bone; 2014 Sep; 66(100):240-50. PubMed ID: 24971713
[TBL] [Abstract][Full Text] [Related]
20. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.
Mercer RR; Miyasaka C; Mastro AM
Clin Exp Metastasis; 2004; 21(5):427-35. PubMed ID: 15672867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
